B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 11.13 USD -0.27% Market Closed
Market Cap: 901.2m USD
Have any thoughts about
Bioventus Inc?
Write Note

Bioventus Inc
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bioventus Inc
Stock-Based Compensation Peer Comparison

Comparables:
HAE
ICUI
ALGN
LNTH
MMSI

Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioventus Inc
NASDAQ:BVS
Stock-Based Compensation
$2.7m
CAGR 3-Years
N/A
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Stock-Based Compensation
$29.1m
CAGR 3-Years
4%
CAGR 5-Years
9%
CAGR 10-Years
8%
ICU Medical Inc
NASDAQ:ICUI
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Stock-Based Compensation
$164.3m
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
17%
Lantheus Holdings Inc
NASDAQ:LNTH
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merit Medical Systems Inc
NASDAQ:MMSI
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Bioventus Inc's Stock-Based Compensation?
Stock-Based Compensation
2.7m USD

Based on the financial report for Dec 31, 2023, Bioventus Inc's Stock-Based Compensation amounts to 2.7m USD.

What is Bioventus Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
-28%

Over the last year, the Stock-Based Compensation growth was -85%.

Back to Top